Sabba Stephen L
SEC insider (Form 3/4/5 filer). CIK 0001442372. Director at LIGAND PHARMACEUTICALS INC (LGND). 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in JUPITER, FL.
Companies Sabba Stephen L has filed insider reports for
- LIGAND PHARMACEUTICALS INC (LGND): Director
Sabba Stephen L
CIK: 0001442372
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LIGAND PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 16, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect2.1K shares at avg. $254.00$545K - Jun 16, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect2.1K shares at avg. $66.13$142K - Jun 5, 2026LGND
LIGAND PHARMACEUTICALS INC
AwardDirect836 shares- - Mar 23, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect1K shares at avg. $207.87$208K - Mar 3, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect2K shares at avg. $201.50$410K - Mar 3, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect2K shares at avg. $69.51$141K - Jun 6, 2025LGND
LIGAND PHARMACEUTICALS INC
AwardDirect1.2K shares- - Apr 1, 2025LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect2.4K shares at avg. $52.30$126K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 2,145 | $254.00 | $544,830 | Direct |
| Jun 16, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 2,145 | $66.13 | $141,849 | Direct |
| Jun 5, 2026 | LGND LIGAND PHARMACEUTICALS INC | Award | 836 | - | $0 | Direct |
| Mar 23, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 1,000 | $207.87 | $207,873 | Direct |
| Mar 3, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 2,034 | $201.50 | $409,851 | Direct |
| Mar 3, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 2,034 | $69.51 | $141,383 | Direct |
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | Award | 1,209 | - | - | Direct |
| Apr 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 2,406 | $52.30 | $125,834 | Direct |
1-8 of 8 transactions